ArticleFrontiers in pharmacology2023

Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov.

Zelei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.